Sanofi-GSK reports success in virus vaccine, after setback May 16, 2021 at 10:05PM

Sanofi and GlaxoSmithKline's potential Covid-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year.